Literature DB >> 30194664

Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.

Shannon L Carpenter1, Jennifer Goldman1, Ashley K Sherman1, David T Selewski2, Mahmoud Kallash3, Cheryl L Tran4, Meredith Seamon5, Chryso Katsoufis6, Isa Ashoor7, Joel Hernandez8, Katarina Supe-Markovina9, Cynthia D'alessandri-Silva10, Nilka DeJesus-Gonzalez11, Tetyana L Vasylyeva12, Cassandra Formeck13, Christopher Woll14, Rasheed Gbadegesin15, Pavel Geier16, Prasad Devarajan17, William E Smoyer3, Bryce A Kerlin3, Michelle N Rheault18,19.   

Abstract

BACKGROUND: Nephrotic syndrome (NS) results in hypercoagulability and increased risk of infection. Furthermore, infection increases the risk of venous thromboembolism (VTE). Our objective was to determine the prevalence of infection, VTE, and the associated outcomes among a cohort of hospitalized children with NS.
METHODS: All children with NS admitted to 17 pediatric hospitals across North America from 2010 to 2012 were included. Prevalence of infection and VTE was determined. Wilcoxon rank-sum and logistic regression were performed.
RESULTS: Seven-hundred thirty hospitalizations occurred among 370 children with NS. One-hundred forty-eight children (40%) had ≥ 1 infection (211 episodes) and 11 (3%) had VTE. Those with VTE had infection more frequently (p = 0.046) and were younger at NS diagnosis (3.0 vs. 4.0 years; p = 0.008). The most common infectious pathogen identified was Streptococcus pneumoniae. The median hospital length of stay for those with infection [10 vs 5 days (p < 0.0001)] or VTE [22 vs 6 days (p < 0.0001)] was longer than those without either complication. Of those with infection, 13% had an intensive care unit (ICU) stay compared with 3.3% of those without infection. Median ICU stay was 4 days in those with VTE compared to 0 days in those without (p < 0.001). By logistic regression, only the number of ICU days was associated with VTE (OR 1.074, 95% CI 1.013-1.138).
CONCLUSIONS: Hospitalized children with NS have high rates of infection. Presence of VTE was associated with infection. Both were associated with longer hospitalizations and ICU stays.

Entities:  

Keywords:  Focal segmental glomerulosclerosis; Infection; Minimal change disease; Nephrotic syndrome; Venous thromboembolism

Year:  2018        PMID: 30194664      PMCID: PMC6628263          DOI: 10.1007/s00467-018-4072-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

Review 1.  Thromboembolic risks and complications in nephrotic children.

Authors:  N Schlegel
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

2.  Inpatient health care utilization in the United States among children, adolescents, and young adults with nephrotic syndrome.

Authors:  Debbie S Gipson; Kassandra L Messer; Cheryl L Tran; Emily G Herreshoff; Joyce P Samuel; Susan F Massengill; Peter Song; David T Selewski
Journal:  Am J Kidney Dis       Date:  2013-02-20       Impact factor: 8.860

3.  Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome.

Authors:  R H McLean; A Forsgren; B Björkstén; Y Kim; P G Quie; A F Michael
Journal:  Pediatr Res       Date:  1977-08       Impact factor: 3.756

Review 4.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

5.  Microbiological spectrum of septicemia and peritonitis in nephrotic children.

Authors:  Y L Tain; G Lin; T W Cher
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

6.  The role of I and B in peritonitis associated with the nephrotic syndrome of childhood.

Authors:  D G Matsell; R J Wyatt
Journal:  Pediatr Res       Date:  1993-07       Impact factor: 3.756

7.  AKI in Children Hospitalized with Nephrotic Syndrome.

Authors:  Michelle N Rheault; Lei Zhang; David T Selewski; Mahmoud Kallash; Cheryl L Tran; Meredith Seamon; Chryso Katsoufis; Isa Ashoor; Joel Hernandez; Katarina Supe-Markovina; Cynthia D'Alessandri-Silva; Nilka DeJesus-Gonzalez; Tetyana L Vasylyeva; Cassandra Formeck; Christopher Woll; Rasheed Gbadegesin; Pavel Geier; Prasad Devarajan; Shannon L Carpenter; Bryce A Kerlin; William E Smoyer
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 8.237

8.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2017.

Authors:  Candice L Robinson; José R Romero; Allison Kempe; Cynthia Pellegrini
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-10       Impact factor: 17.586

Review 9.  The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis.

Authors:  Andrew S Kimball; Andrea T Obi; Jose A Diaz; Peter K Henke
Journal:  Front Immunol       Date:  2016-06-27       Impact factor: 7.561

Review 10.  The non-immunosuppressive management of childhood nephrotic syndrome.

Authors:  James McCaffrey; Rachel Lennon; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2015-11-10       Impact factor: 3.714

View more
  7 in total

Review 1.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Authors:  Agnes Trautmann; Olivia Boyer; Elisabeth Hodson; Arvind Bagga; Debbie S Gipson; Susan Samuel; Jack Wetzels; Khalid Alhasan; Sushmita Banerjee; Rajendra Bhimma; Melvin Bonilla-Felix; Francisco Cano; Martin Christian; Deirdre Hahn; Hee Gyung Kang; Koichi Nakanishi; Hesham Safouh; Howard Trachtman; Hong Xu; Wendy Cook; Marina Vivarelli; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2022-10-21       Impact factor: 3.651

Review 2.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

Authors:  Agnes Trautmann; Marina Vivarelli; Susan Samuel; Debbie Gipson; Aditi Sinha; Franz Schaefer; Ng Kar Hui; Olivia Boyer; Moin A Saleem; Luciana Feltran; Janina Müller-Deile; Jan Ulrich Becker; Francisco Cano; Hong Xu; Yam Ngo Lim; William Smoyer; Ifeoma Anochie; Koichi Nakanishi; Elisabeth Hodson; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2020-05-07       Impact factor: 3.714

3.  Risk factors for the development of hospital-acquired pediatric venous thromboembolism-Dealing with potentially causal and confounding risk factors using a directed acyclic graph (DAG) analysis.

Authors:  Leonardo Rodrigues Campos; Maurício Petroli; Flavio Roberto Sztajnbok; Elaine Sobral da Costa; Leonardo Rodrigues Brandão; Marcelo Gerardin Poirot Land
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

4.  Cerebral Venous Sinus Thrombosis in a Child With Idiopathic Nephrotic Syndrome: A Case Report and Review of the Literature.

Authors:  Jiali He; Fang Yang
Journal:  Cureus       Date:  2020-10-29

5.  Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge.

Authors:  Cheryl L Tran; David T Selewski; Gia J Oh; Jonathan P Troost; Susan F Massengill; Samhar I Al-Akash; Shefali Mahesh; Rasheda Amin; Isa F Ashoor; Rahul Chanchlani; Mahmoud Kallash; Robert P Woroniecki; Debbie S Gipson
Journal:  Front Pediatr       Date:  2021-02-05       Impact factor: 3.418

Review 6.  Molecular Mechanisms of Proteinuria in Minimal Change Disease.

Authors:  Shrey Purohit; Federica Piani; Flor A Ordoñez; Carmen de Lucas-Collantes; Colin Bauer; Gabriel Cara-Fuentes
Journal:  Front Med (Lausanne)       Date:  2021-12-23

7.  Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.

Authors:  Cristina E Alcorta; Adam R Kronish; Matthew L Lorenz
Journal:  IDCases       Date:  2021-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.